Who is sponsoring NCT01094366?

NCT01094366 is sponsored by Oregon Health and Science University.

What drugs are being tested in NCT01094366?

Interventions in NCT01094366: Paracervical Block, Sham Paracervical Block.

What condition does NCT01094366 study?

NCT01094366 studies Legal Abortion With Complication, Pain.

Is NCT01094366 still recruiting?

NCT01094366 is currently completed. Last updated 24 December 2019.

Last reviewed 2019-12-24 · How we verify

NCT01094366

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

An Evaluation of the Paracervical Block for Pain Control in First Trimester Surgical Abortion

Completed Phase 4 Last updated 24 December 2019

What this trial tests

Phase 4 trial testing Paracervical Block in Legal Abortion With Complication in 121 participants. Completed in 1 November 2012.

Timeline

1 April 2010

Primary endpoint
1 October 2010

1 November 2012

Quick facts

Lead sponsor	Oregon Health and Science University
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	diagnostic
Enrollment	121
Start date	1 April 2010
Primary completion	1 October 2010
Estimated completion	1 November 2012
Sites	1 location across United States

Drugs / interventions tested

Paracervical Block — full drug profile →
Sham Paracervical Block — full drug profile →

Conditions studied

Legal Abortion With Complication — all drugs for Legal Abortion With Complication →
Pain — all drugs for Pain →

Sponsor

Oregon Health and Science University

Who can join

Adults 18 to 60, female only, with Legal Abortion With Complication or Pain. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Pain reported with cervical dilation
Time frame: 1 Year
Distance (mm) from the left of the 100-mm VAS scale (reflecting magnitude of pain) recorded at time of cervical dilation.

Sponsor's own description

Many woman undergoing a surgical abortion receive a paracervical nerve block for pain reduction, in which lidocaine (a numbing medication) is injected around the cervix. These injections numb the cervix and possibly the lower part of the uterus. However, the injection can be uncomfortable and it is not well known whether it is effective in reducing pain. The purpose of this study is to determine the level of pain women experience with a surgical abortion and the effect that paracervical block might have on that pain.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Paracervical block for pain control in first-trimester surgical abortion: a randomized controlled trial.
Renner RM, Nichols MD, Jensen JT, Li H, et al · · 2012 · cited 42× · PMID 22525915 · DOI 10.1097/aog.0b013e318250b13e

Verify or expand the search:

Other trials of Paracervical Block

Trials testing the same drug.

NCT04572828 — Effectiveness of Paracervical Block in Endometrial Sampling Procedures for Pain Control · NA · completed
NCT02354092 — Paracervical Block for Pain Control With Osmotic Dilator Placement · NA · terminated

Other Oregon Health and Science University trials

Trials by the same sponsor.

NCT07431970 — Assessing Construction Execution Under Sleep Impairment · NA · not yet recruiting
NCT07309757 — Maternal Outcomes With Methamphetamine Use and Cardiac Assessment for Rural Dissemination (MOM CARD) · not yet recruiting
NCT07282639 — App-Based Certified Diabetes Education Therapy (AB-CDE) · NA · not yet recruiting
NCT07322588 — Reentry Incentives and Support for Engagement With Contingency Management · NA · not yet recruiting
NCT07220590 — Implementing Powered Mobility in Early Childhood Settings for Children With Cerebral Palsy · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01094366 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Oregon Health and Science University
Last refreshed: 24 December 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01094366.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing